Several natural or synthesized small molecules have been demonstrated to suppress the formation of α-synuclein fibrils, and some of these compounds are potential therapeutic agents for neurodegeneration diseases associated with α-synuclein aggregation.50–56. The gene discussed is SNCA; the disease is neurodegenerative disease.